Quiros, Stenger & Kelly contemplate joint vs. separate trials in biomedical fraud case

Posted by GCBI Team on February 12, 2020

The trio behind the Jay Peak story, the largest EB-5 investment fraud ever, are deciding whether they would prefer to be tried together in the AnC Bio Vermont case where more than $80 million EB-5 dollars were raised but the project was never built. A reason to have joint trials would be if one party believes they are less culpable. Stenger’s attorney admits that a motion for separate trials is rarely granted.

Read the VTDigger article


Please Login or Register